Author

Hongxiang Wang

Institutions: First Affiliated Hospital of Henan University of Science and Technology, Central Hospital of Wuhan, Huazhong University of Science and Technology

Observed institutions: First Affiliated Hospital of Henan University of Science and Technology, Central Hospital of Wuhan, Huazhong University of Science and Technology

OpenAlex ID: A5124018113

CD7 CAR-T cells eliminate chronic myeloid leukemia stem cells specifically and effectively

2026 · Wenjing Zhang, Haobing Wang, et al. · Hematology

Dual targeting of BCR::ABL1 and DNA methylation in advanced CML: A 3-year survival analysis of TKI-Azacitidine combination therapy

2026 · Zhuming Yang, Danlei Han, et al. · Therapeutic Advances in Hematology

Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia

2026 · Jiaxin Wu, Hongxiang Wang · Frontiers in Hematology

The Comparison of First-Line Dasatinib Therapy 70 mg/day Versus 100 mg/day in Newly Diagnosed Patients with Chronic Myeloid Leukemia in the Chronic Phase: a Prospective, Randomized, Multicenter 1-year Clinical Study

2026 · Dan Yu, Zhuangzhi Yang, et al. · Indian Journal of Hematology and Blood Transfusion

Works count: 5

Citation count:

H-index:

I10-index: